Home
Search:
1146 feeds
357 categories
932 articles (<24 hours)
28 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

Science


RSS FeedsMerck Presents Interim Findings from Phase 2a Clinical Trial Evaluating Investigational Once-Monthly Oral Islatravir for ...
(WorldNews Health)

 
 

26 january 2021 16:33:08

 
Merck Presents Interim Findings from Phase 2a Clinical Trial Evaluating Investigational Once-Monthly Oral Islatravir for ...
(WorldNews Health)
 


KENILWORTH, N.J.--(BUSINESS WIRE)--Jan 26, 2021-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new interim data from the Phase 2a trial (NCT04003103) in adults evaluating the safety, tolerability and pharmacokinetics (PK) of the once-monthly oral islatravir tablet -- the company`s investigational oral nucleoside reverse transcriptase translocation inhibitor (NRTTI) -- for pre-exposure prophylaxis (PrEP). Interim findings demonstrate that once-monthly oral islatravir achieved the pre-specified efficacy PK threshold for PrEP at both of the two doses studied (60 mg and 120 mg). In the interim analysis using blinded data, both monthly doses of islatravir...


 
13 viewsCategory: Science > Medicine
 
Woebot Health Names Timothy Mariano Vice President and Medical Director
(WorldNews Health)
Thai court acquits 80-year-old writer of defaming monarchy
(WorldNews Health)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2021 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten